Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO)

Clinical trial NCT03449719 · UNKNOWN

Trial details

NCT number: NCT03449719
Sponsor: Lorenzo Livi
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone

Start date: 2018-05-01
Primary completion: 2021-09-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.